Techna was engaged by Jenex to assess their TherOZap™ technology for the inactivation of Zika virus in cultured cells. The study is now complete and Jenex has received the results — read the summary of the study in Jenex’s press release here.
https://technainstitute.com/wp-content/uploads/2016/03/LatestNews1-1024x379.jpg
1024
379
Techna
Techna
https://technainstitute.com/wp-content/uploads/2016/03/LatestNews1-1024x379.jpg